Report workspace tools

NCT03166566COMPLETEDanonymous

Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.

Sponsor

Source record

Federal University of Minas Gerais

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Laminar drainage implant surgery.

Indication / condition

AI-normalized

Glaucoma

Intervention

Source record

Laminar drainage implant surgery.

Source & freshness

Source record

NCT ID

NCT03166566

Original source

ClinicalTrials.gov

Source last updated

May 25, 2017

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03166566

Title

Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.

Sponsor

Federal University of Minas Gerais

Status

COMPLETED

Phase

NA

Condition raw

Glaucoma, Blindness, Acquired, End-Stage Glaucoma, Glaucoma Traumatic

Condition normalized

Glaucoma, Blindness, Acquired, End-Stage Glaucoma, Glaucoma Traumatic

Modality raw

medical device

Modality normalized

medical device

Target raw

Laminar drainage implant surgery.

Target normalized

Laminar drainage implant surgery.

Interventions

Laminar drainage implant surgery.

Public preview

Source record

Purpose: To assess the feasibility of a surgical technique and present the preliminary safety results of a new glaucoma device devoid of a tube in painful blind eyes.

Methods: Fifteen end-stage glaucomatous eyes without light perception vision were treated with a novel laminar drainage implant. Intraocular pressure was measured preoperatively and up to 24 months after surgery using a Goldmann applanation tonometer. A scale ranging from 0 to 10 was used to evaluate ocular pain. Conjunctival hyperemia, discharge, erosion or retraction, aqueous humor leakage, corneal edema, hyphema, anterior chamber cells and depth, dislocation of the implant, and filtering bleb height were assessed by slit-lamp biomicroscopy. Anterior segment optical coherence tomography was also assessed.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.